Pfizer/PFE

$26.89

-1.03%
-
1D1W1MYTD1YMAX

About Pfizer

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1. Biopharma is engaged in the science-based biopharmaceutical business. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. The Company’s primary care products include Eliquis, Nurtec ODT/Vydura and the Premarin family; the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba; Comirnaty, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Eucrisa/Staquis and Cibinqo; the Vyndaqel family, Oxbryta, BeneFIX and Genotropin, and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend and Panzyga. Its oncology products include Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena and Braftovi.

Ticker

PFE

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Albert Bourla

Employees

88,000

Headquarters

New york, United States

Pfizer Metrics

BasicAdvanced
$156.74B
Market cap
77.85
P/E ratio
$0.36
EPS
0.60
Beta
$1.64
Dividend rate
6.05%
Dividend yield

What the Analysts think about Pfizer

Analyst Ratings

Majority rating from 26 analysts.
Hold

Price Targets

Average projection from 22 analysts.
20.19% upside
High $50.00
Low $26.00
$26.89
Current price
$32.32
Average price target

Pfizer Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-23.64% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$14.25B
7.69%
Net income
$-3.37B
41.44%
Profit margin
-23.64%
31.33%

Pfizer Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 145.84%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.23
$0.67
-$0.17
$0.10
-
Expected
$0.98
$0.57
-$0.34
-$0.22
$0.52
Surprise
25.81%
18.02%
-49.39%
-145.84%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Pfizer stock

Buy or sell Pfizer stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing